Description
RATIFICATION FOR DRUG ORDER
First action · last action
2013-09-25 · 2014-06-20
Transactions
2
First transaction's obligation
$154,695
Base + all options value (sum of deltas)
$146,452
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5096B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-09-25+$154,695= $154,695
- Mod P000012014-06-20-$8,243= $146,452
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-09-25 | +$154,695 | $154,695 | RATIFICATION FOR DRUG ORDER |
| Mod P00001· FUNDING ONLY ACTION | 2014-06-20 | −$8,243 | $146,452 | RATIFICATION FOR DRUG ORDER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KK5FBFA43JS7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0777 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $33,158 | FY2026 |
| 36C24526N0755 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0754 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $15,746 | FY2026 |
| 36C24526N0723 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0722 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
| 36C24526N0707 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,352 | FY2026 |
Other recipients under 6515 from 596-LEXINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24916P0598 | MEDTRONIC INC | 596-LEXINGTON | $8,700 | FY2016 |
| VA24916P2032 | STRYKER CORPORATION | 596-LEXINGTON | $643,063 | FY2016 |
| VA24916J1849 | KARL STORZ ENDOSCOPY-AMERICA INC | 596-LEXINGTON | $5,106 | FY2016 |
| VA24916P1825 | PROAIM AMERICAS, LLC. | 596-LEXINGTON | $8,295 | FY2016 |
| VA24916F1796 | GERMFREE LABORATORIES, LLC | 596-LEXINGTON | $41,064 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24913J4431_3600_V797P5096B_3600 · retrieved 2026-09-26.